779
Views
0
CrossRef citations to date
0
Altmetric
Infectious Diseases

Economic burden and secondary complications of influenza-related hospitalization among adults in the US: a retrospective cohort study

ORCID Icon, , , , , , & show all
Pages 324-336 | Received 11 Dec 2023, Accepted 01 Feb 2024, Published online: 22 Feb 2024

References

  • Centers for Disease Control and Prevention. Past seasons estimated influenza disease burden: U.S. Department of Health & Human Services; 2022 [updated October 18, 2022; cited 2023 October]. Available from: https://www.cdc.gov/flu/about/burden/past-seasons.html.
  • Mauskopf J, Klesse M, Lee S, et al. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ. 2013;16(2):264–277. doi: 10.3111/13696998.2012.752376.
  • Macias AE, McElhaney JE, Chaves SS, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39 Suppl 1(Suppl 1):A6–A14. doi: 10.1016/j.vaccine.2020.09.048.
  • Centers for Disease Control and Prevention. People at higher risk of flu complications: U.S. Department of Health & Human Services; 2023 [updated August 25, 2023; cited 2023 October]. Available from: https://www.cdc.gov/flu/highrisk/index.htm.
  • Hartnett J, Donga P, Ispas G, et al. Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the hospitalized acute respiratory tract infection study. Influenza Other Respir Viruses. 2022;16(5):906–915. doi: 10.1111/irv.12994.
  • Reed C, Chaves SS, Perez A, et al. Complications among adults hospitalized with influenza: a comparison of seasonal influenza and the 2009 H1N1 pandemic. Clin Infect Dis. 2014;59(2):166–174. doi: 10.1093/cid/ciu285.
  • Rothberg MB, Haessler SD, Brown RB. Complications of viral influenza. Am J Med. 2008;121(4):258–264. doi: 10.1016/j.amjmed.2007.10.040.
  • Sellers SA, Hagan RS, Hayden FG, et al. The hidden burden of influenza: a review of the extra-pulmonary complications of influenza infection. Influenza Other Respir Viruses. 2017;11(5):372–393. doi: 10.1111/irv.12470.
  • Putri W, Muscatello DJ, Stockwell MS, et al. Economic burden of seasonal influenza in the United States. Vaccine. 2018;36(27):3960–3966. doi: 10.1016/j.vaccine.2018.05.057.
  • de Courville C, Cadarette SM, Wissinger E, et al. The economic burden of influenza among adults aged 18 to 64: a systematic literature review. Influenza Other Respir Viruses. 2022;16(3):376–385. doi: 10.1111/irv.12963.
  • Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine. 2007;25(27):5086–5096. doi: 10.1016/j.vaccine.2007.03.046.
  • Young-Xu Y, van Aalst R, Russo E, et al. The annual burden of seasonal influenza in the US veterans affairs population. PLoS One. 2017;12(1):e0169344. doi: 10.1371/journal.pone.0169344.
  • Karve S, Misurski D, Herrera-Taracena G, et al. Annual all-cause healthcare costs among influenza patients with and without influenza-related complications: analysis of a United States managed care database. Appl Health Econ Health Policy. 2013;11(2):119–128. doi: 10.1007/s40258-013-0020-6.
  • Federici C, Cavazza M, Costa F, et al. Health care costs of influenza-related episodes in high income countries: a systematic review. PLoS One. 2018;13(9):e0202787. doi: 10.1371/journal.pone.0202787.
  • Reed C, Chaves SS, Daily Kirley P, et al. Estimating influenza disease burden from population-based surveillance data in the United States. PLoS One. 2015;10(3):e0118369. doi: 10.1371/journal.pone.0118369.
  • Goldstein E, Viboud C, Charu V, et al. Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology. 2012;23(6):829–838. doi: 10.1097/EDE.0b013e31826c2dda.
  • Lee CC, Liu Y, Lu KT, et al. Comparison of influenza hospitalization outcomes among adults, older adults, and octogenarians: a US national population-based study. Clin Microbiol Infect. 2021;27(3):435–442. doi: 10.1016/j.cmi.2020.04.013.
  • Karve S, Meier G, Davis KL, et al. Influenza-related health care utilization and productivity losses during seasons with and without a match between the seasonal and vaccine virus B lineage. Vaccine. 2013;31(33):3370–3388. doi: 10.1016/j.vaccine.2013.04.081.
  • PINC AI Applied Sciences, Premier Inc. PINC AI Healthcare Database: data that informs and performs (White Paper). 2023. https://offers.pinc-ai.com/PINC-AI-Healthcare-Database-White-Paper-LP.html.
  • Centers for Disease Control and Prevention. 2020-2021 flu season summary: U.S. Department of Health & Human Services; 2021 [updated October 25, 2021; cited 2024 January]. Available from: https://www.cdc.gov/flu/season/faq-flu-season-2020-2021.htm.
  • Centers for Disease Control and Prevention. Flu season: U.S. Department of Health & Human Services; 2022 [updated September 20, 2022; cited 2023 October]. Available from: https://www.cdc.gov/flu/about/season/index.html.
  • Centers for Disease Control and Prevention. Influenza activity in the United States during the 2022–23 season and composition of the 2023–24 influenza vaccine: U.S. Department of Health & Human Services; 2023 [updated September 28, 2023; cited 2023 October]. Available from: https://www.cdc.gov/flu/spotlights/2023-2024/22-23-summary-technical-report.htm.
  • US Bureau of Labor Statistics. Consumer Price Index (CPI) Databases: US Department of Labor; 2023 [cited 2023 November 12]. Available from: https://www.bls.gov/cpi/data.htm.
  • Centers for Disease Control and Prevention. Influenza ACIP vaccine recommendations: U.S. Department of Health & Human Services; 2023 [updated August 23, 2023; cited 2024 January]. Available from: https://www.cdc.gov/vaccines/hcp/acip-recs/vacc-specific/flu.html.
  • Centers for Disease Control and Prevention. Preliminary estimated influenza illnesses, medical visits, hospitalizations, and deaths in the United States—2022–2023 Influenza Season Atlanta, GA: U.S. Department of Health & Human Services; 2022 [updated November 22, 2023; cited 2024 January]. Available from: https://www.cdc.gov/flu/about/burden/2022-2023.htm.
  • Centers for Disease Control and Prevention. Frequently asked questions about estimated flu burden: U.S. Department of Health & Human Services; 2021 [updated October 21, 2021; cited 2023 November]. Available from: https://www.cdc.gov/flu/about/burden/faq.htm.
  • Kim DeLuca E, Gebremariam A, Rose A, et al. Cost-effectiveness of routine annual influenza vaccination by age and risk status. Vaccine. 2023;41(29):4239–4248. doi: 10.1016/j.vaccine.2023.04.069.
  • Arriola C, Garg S, Anderson EJ, et al. Influenza vaccination modifies disease severity among community-dwelling adults hospitalized with influenza. Clin Infect Dis. 2017;65(8):1289–1297. doi: 10.1093/cid/cix468.
  • Arriola CS, Anderson EJ, Baumbach J, et al. Does influenza vaccination modify influenza severity? Data on older adults hospitalized with influenza during the 2012-2013 season in the United States. J Infect Dis. 2015;212(8):1200–1208. doi: 10.1093/infdis/jiv200.
  • Ferdinands JM, Thompson MG, Blanton L, et al. Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further research. Vaccine. 2021;39(28):3678–3695. doi: 10.1016/j.vaccine.2021.05.011.
  • Regan AK, Arriola CS, Couto P, et al. Severity of influenza illness by seasonal influenza vaccination status among hospitalised patients in four South American countries, 2013-19: a surveillance-based cohort study. Lancet Infect Dis. 2023;23(2):222–232. doi: 10.1016/S1473-3099(22)00493-5.
  • Centers for Disease Control and Prevention. Flu vaccination coverage, United States, 2022–23 Influenza Season: U.S. Department of Health & Human Services; 2023 [updated October 10, 2023; cited 2023 October]. Available from: https://www.cdc.gov/flu/fluvaxview/coverage-2223estimates.htm.
  • Sumner KM, Masalovich S, O'Halloran A, et al. Severity of influenza-associated hospitalisations by influenza virus type and subtype in the USA, 2010-19: a repeated cross-sectional study. Lancet Microbe. 2023;4(11):e903–e912. doi: 10.1016/S2666-5247(23)00187-8.
  • Swierczynska M, Mirowska-Guzel DM, Pindelska E. Antiviral drugs in influenza. Int J Environ Res Public Health. 2022;19(5):3018.
  • Uyeki TM, Bernstein HH, Bradley JS, et al. Clinical practice guidelines by the infectious diseases society of America: 2018 update on diagnosis, treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza. Clin Infect Dis. 2019;68(6):895–902. doi: 10.1093/cid/ciy874.
  • Hamilton MA, Calzavara A, Emerson SD, et al. Validating international classification of disease 10th revision algorithms for identifying influenza and respiratory syncytial virus hospitalizations. PLoS One. 2021;16(1):e0244746. doi: 10.1371/journal.pone.0244746.